Due to concerns surrounding its effectiveness, the US Food and Drug Administration (FDA) ended the Rare Pediatric Disease Designation (RPDD) programme in late 2024.

Boston conference will explore strategic partnering, device innovation, and delivery solutions for emerging therapeutics.

Johnson & Johnson reported second-quarter results on July 16. Sales of pharmaceuticals have been muted due to a loss of ...

Overview of Nanotechnology Drug Delivery MarketThe global Nanotechnology Drug Delivery Market is valued at USD 97.98 Billion ...

McKesson is all set to release its fiscal first-quarter earnings next month, and analysts project a single-digit earnings growth.

Drug discovery has long been criticized for its slow, costly, and failure-prone nature. Traditional approaches, particularly ...

The Novo Nordisk Foundation, the non-profit which controls pharmaceutical giant Novo Nordisk, and Denmark's Export and ...

Funding will be used to establish the clinical utility of OneMap™, a proprietary artificial intelligence (AI) driven single cell transcriptomic oncology ...

Blossom Media, in association with Ensemble International and EuroBritain Certifications – U.K., recently concluded the first ...

The Sri Lanka Export Development Board (EDB) initiated a constructive dialogue with the National Initiative for R&D ...

Siksha ‘O’ Anusandhan (SOA), a Deemed to be University in Bhubaneswar, has been pivotal in producing professionals across various disciplines since its establishment in 2007. With over 18,000 students ...

Stakeholders have emphasized that creating a sustainable future for pharmacy practice can be most effectively accomplished ...